Squarepoint’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.91M | Buy |
54,162
+28,431
| +110% | +$2.71M | 0.01% | 1377 |
|
|
2025
Q4 | $2.09M | Sell |
25,731
-9,256
| -26% | -$797K | ﹤0.01% | 2029 |
|
|
2025
Q3 | $3.06M | Sell |
34,987
-12,083
| -26% | -$1.08M | ﹤0.01% | 1769 |
|
|
2025
Q2 | $3.91M | Sell |
47,070
-4,523
| -9% | -$378K | ﹤0.01% | 1625 |
|
|
2025
Q1 | $4.33M | Sell |
51,593
-14,580
| -22% | -$1.36M | 0.01% | 1508 |
|
|
2024
Q4 | $6.1M | Sell |
66,173
-16,612
| -20% | -$1.6M | 0.01% | 1483 |
|
|
2024
Q3 | $7.69M | Buy |
82,785
+47,143
| +132% | +$4.08M | 0.01% | 1120 |
|
|
2024
Q2 | $2.93M | Sell |
35,642
-2,000
| -5% | -$147K | ﹤0.01% | 1762 |
|
|
2024
Q1 | $2.5M | Sell |
37,642
-19,015
| -34% | -$1.17M | ﹤0.01% | 1946 |
|
|
2023
Q4 | $3.22M | Buy |
56,657
+45,227
| +396% | +$2.37M | 0.01% | 1680 |
|
|
2023
Q3 | $623K | Buy |
11,430
+5,105
| +81% | +$303K | ﹤0.01% | 2628 |
|
|
2023
Q2 | $426K | Sell |
6,325
-1,599
| -20% | -$97.5K | ﹤0.01% | 2730 |
|
|
2023
Q1 | $408K | Buy |
+7,924
| New | +$385K | ﹤0.01% | 2411 |
|
|
2022
Q3 | – | Sell |
-5,827
| Closed | -$265K | – | 3229 |
|
|
2022
Q2 | $265K | Sell |
5,827
-866
| -13% | -$38.7K | ﹤0.01% | 2348 |
|
|
2022
Q1 | $311K | Buy |
+6,693
| New | +$299K | ﹤0.01% | 2257 |
|
|
2021
Q3 | – | Sell |
-6,353
| Closed | -$388K | – | 3199 |
|
|
2021
Q2 | $388K | Sell |
6,353
-6,350
| -50% | -$337K | ﹤0.01% | 2331 |
|
|
2021
Q1 | $620K | Buy |
12,703
+6,377
| +101% | +$299K | ﹤0.01% | 1859 |
|
|
2020
Q4 | $256K | Buy |
+6,326
| New | +$226K | ﹤0.01% | 2336 |
|
|
2020
Q3 | – | Sell |
-11,228
| Closed | -$296K | – | 2684 |
|
|
2020
Q2 | $296K | Sell |
11,228
-4,572
| -29% | -$120K | ﹤0.01% | 1609 |
|
|
2020
Q1 | $394K | Buy |
+15,800
| New | +$488K | 0.01% | 1163 |
|
|
2019
Q4 | – | Sell |
-13,716
| Closed | -$469K | – | 2658 |
|
|
2019
Q3 | $469K | Buy |
13,716
+1,251
| +10% | +$40K | ﹤0.01% | 1656 |
|
|
2019
Q2 | $349K | Buy |
+12,465
| New | +$346K | ﹤0.01% | 1859 |
|
|
2018
Q4 | – | Sell |
-6,462
| Closed | -$250K | – | 2113 |
|
|
2018
Q3 | $250K | Buy |
+6,462
| New | +$233K | ﹤0.01% | 1637 |
|
|
2018
Q2 | – | Sell |
-8,344
| Closed | -$302K | – | 1920 |
|
|
2018
Q1 | $302K | Sell |
8,344
-4,502
| -35% | -$156K | ﹤0.01% | 1316 |
|
|
2017
Q4 | $409K | Sell |
12,846
-1,747
| -12% | -$59.8K | 0.01% | 1318 |
|
|
2017
Q3 | $546K | Sell |
14,593
-103
| -0.7% | -$3.51K | 0.01% | 946 |
|
|
2017
Q2 | $459K | Buy |
14,696
+2,727
| +23% | +$78.8K | 0.01% | 988 |
|
|
2017
Q1 | $295K | Sell |
11,969
-3,536
| -23% | -$83K | 0.01% | 1085 |
|
|
2016
Q4 | $393K | Buy |
+15,505
| New | +$344K | 0.02% | 964 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Squarepoint's LMAT Position: Q1 2026 in Review
Squarepoint increased its LeMaitre Vascular (LMAT) stake by 110% in Q1 2026, buying an estimated $2.71M and bringing the position to 54,162 shares worth $5.91M. The position accounts for 0.01% of the portfolio, ranked #1377.
Squarepoint first reported a position in LMAT in Q4 2016 and has held it in 29 quarters since. The position peaked at $7.69M in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Squarepoint held 54,162 shares of LeMaitre Vascular worth $5.91M as of Q1 2026.
- Squarepoint bought 28,431 LeMaitre Vascular shares in Q1 2026, an estimated $2.71M.
- LeMaitre Vascular made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1377 holding.
- Squarepoint first reported a position in LeMaitre Vascular in Q4 2016 and has held it in 29 quarters since.
- Squarepoint's LeMaitre Vascular position peaked at $7.69M in Q3 2024.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.